drugset / Trial / NCT00488124
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NaSingle-groupOpen-labelTreatment
Summary
Growth hormone therapy will improve the height of short statured children with pathological conditions that lead to growth retardation. Growth hormone therapy will show an increase in height velocity \>1 SD compared to pretreatment height velocity. and the therapy will be safe.
Timeline
- Start
- 2005-11
- Primary completion
- 2011-02
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.035 mg/kg | Subcutaneous |